Replies to post #107919 on Amarantus Bioscience Holdings Inc (AMBS)

[docoroc2]

Amarantus to Present at Upcoming Investor Conferences

Aug 19, 2014 08:41:00 (ET)


Amarantus to Present at Upcoming Investor Conferences

SAN FRANCISCO, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that Gerald Commissiong, President and CEO, is scheduled to present to investors at the 16th Annual Rodman & Renshaw Healthcare Conference to be held September 8-10, 2014 at the New York Palace Hotel in New York City. The presentation is scheduled for Tuesday, September 9th at 2:30 PM ET and will be web cast live, please visit the Company's IR Events section to participate. Additional information about the conference can be found at http://www.rodm.com/.

Mr. Commissiong is also scheduled to present at the Aegis Capital Healthcare and Technology Conference to be held at the Wynn Las Vegas on September 10-13, 2014. His presentation will take place on Thursday, September 11(th) at 2:30 PM PT. Conference information may be found at http://www.meetmax.com/sched/event_25932/public/conference_home.html?event_id=25932.

Amarantus will also be participating in the First Annual Zacks Healthcare Meetup on Monday, September 8th.

Attendees who wish to meet with management one on one may contact the conference organizers or our Investor Relations department at [e-mail]